Dr Matthew Eliot Woodske, MD | |
1000 Dutch Ridge Rd, Beaver, PA 15009-9727 | |
(724) 773-6403 | |
(724) 770-7943 |
Full Name | Dr Matthew Eliot Woodske |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 23 Years |
Location | 1000 Dutch Ridge Rd, Beaver, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114957990 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Heritage Valley Beaver | Beaver, PA | Hospital |
Heritage Valley Sewickley | Sewickley, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Heritage Valley Multispecialty Group Inc | 0042105678 | 235 |
News Archive
Heart disease is the leading cause of death among both men and women in the United States, but according to the American Heart Association, it is preventable 80 percent of the time.
Mylan Inc. today announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, 15 mg and 30 mg.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2010.
Studies published of early results of the strategic collaboration between Beckman Coulter Genomics and Linding Lab at UCPH.
Resverlogix Corp. announced today that key scientific data was communicated in an oral presentation highlighting the novel features of RVX-208, the Company's lead drug, during the Atherosclerosis, Thrombosis, Vascular Biology conference being held in San Francisco, California.
› Verified 1 days ago
Entity Name | Heritage Valley Multispecialty Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528015401 PECOS PAC ID: 0042105678 Enrollment ID: O20040220000870 |
News Archive
Heart disease is the leading cause of death among both men and women in the United States, but according to the American Heart Association, it is preventable 80 percent of the time.
Mylan Inc. today announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, 15 mg and 30 mg.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2010.
Studies published of early results of the strategic collaboration between Beckman Coulter Genomics and Linding Lab at UCPH.
Resverlogix Corp. announced today that key scientific data was communicated in an oral presentation highlighting the novel features of RVX-208, the Company's lead drug, during the Atherosclerosis, Thrombosis, Vascular Biology conference being held in San Francisco, California.
› Verified 1 days ago
Entity Name | University Of Pittsburgh Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
Heart disease is the leading cause of death among both men and women in the United States, but according to the American Heart Association, it is preventable 80 percent of the time.
Mylan Inc. today announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, 15 mg and 30 mg.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2010.
Studies published of early results of the strategic collaboration between Beckman Coulter Genomics and Linding Lab at UCPH.
Resverlogix Corp. announced today that key scientific data was communicated in an oral presentation highlighting the novel features of RVX-208, the Company's lead drug, during the Atherosclerosis, Thrombosis, Vascular Biology conference being held in San Francisco, California.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Matthew Eliot Woodske, MD 1000 Dutch Ridge Rd, Beaver, PA 15009-9727 Ph: (724) 773-6403 | Dr Matthew Eliot Woodske, MD 1000 Dutch Ridge Rd, Beaver, PA 15009-9727 Ph: (724) 773-6403 |
News Archive
Heart disease is the leading cause of death among both men and women in the United States, but according to the American Heart Association, it is preventable 80 percent of the time.
Mylan Inc. today announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, 15 mg and 30 mg.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months ended March 31, 2010.
Studies published of early results of the strategic collaboration between Beckman Coulter Genomics and Linding Lab at UCPH.
Resverlogix Corp. announced today that key scientific data was communicated in an oral presentation highlighting the novel features of RVX-208, the Company's lead drug, during the Atherosclerosis, Thrombosis, Vascular Biology conference being held in San Francisco, California.
› Verified 1 days ago
Dr. Ramon Torres Castaneda, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 130 Taylor Ave, Beaver, PA 15009 Phone: 724-454-7676 | |
Dr. Kenneth Wayne House, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Heart And Vascular Center, 605 Sharon Rd., Beaver, PA 15009 Phone: 724-773-4502 Fax: 724-770-7906 | |
Gerald R Medwick, D.O. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-7616 Fax: 724-773-4673 | |
Perry Tiberio, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Dutch Ridge Rd, Beaver, PA 15009 Phone: 724-773-6405 | |
Megan Nicole Gallo, CRNP Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 246 Friendship Cir, Beaver, PA 15009 Phone: 878-201-3312 | |
Dr. Joseph W. Rooney, M.D. Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 701 Sharon Rd, Suite 1, Beaver, PA 15009 Phone: 724-728-9202 |